Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation
Wei et al., Emerging Microbes & Infections, doi:10.1080/22221751.2025.2469648
https://c19early.org/wei5.html